Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Lupin

Lupin

BSE: 500257|NSE: LUPIN|ISIN: INE326A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 12, 16:00
845.00
7.3 (0.87%)
VOLUME 143,803
LIVE
NSE
Dec 12, 15:59
846.80
7.65 (0.91%)
VOLUME 2,487,565
News on Lupin
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Lupin, Kaveri Seed; sell Hero Motocorp: Rajat Bose 

1.57 pm | 12 Dec 2017 |  Source: CNBC-TV18

Rajat Bose of rajatkbose.com advises buying Lupin and Kaveri Seed Company....

Buy Lupin, Dalmia Bharat: Mitessh Thakkar 

2.37 pm | 11 Dec 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com advises buying Lupin and Dalmia Bharat....

Lupin tumbles 1% on drug recall news

9.54 am | 30 Nov 2017 |  Source: Moneycontrol.com

The company is recalling a single lot of Pravastatin Sodium USP tablets in the US, according to the US Food and Drug Administration (USFDA)....

Lupin recalls cholesterol lowering tablets in US

6.59 pm | 29 Nov 2017 |  Source: PTI

As per the information on the USFDA site, Lupin is voluntarily recalling the product due to "a pharmacy complaint where one Duloxetine delayed-release...

Remain invested in Lupin: Gaurang Shah 

3.42 pm | 20 Nov 2017 |  Source: CNBC-TV18

Gaurang Shah of Geojit Financial Services is of the view that one may remain invested in Lupin....

USFDA issues warning letter to Lupin's Goa, Indore plants

7.34 pm | 16 Nov 2017 |  Source: PTI

The US Food and Drug Administration (USFDA) has issued a warning letter to Lupin for violation of current good manufacturing practice norms at two of ...

Buy Lupin; target of Rs 1140: JM Financial

4.14 pm | 13 Nov 2017 |  Source: Moneycontrol.com

JM Financial is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1140 in its research report dated October 31, 2017....

Hold Lupin; target of Rs 1050: Sharekhan

11.17 am | 09 Nov 2017 |  Source: Moneycontrol.com

Sharekhan recommended hold rating on Lupin with a target price of Rs 1050 in its research report dated October 30, 2017....

USFDA warning: Lupin sees marginal impact on earnings; resolution to take 12-15 mths 

11.40 am | 08 Nov 2017 |  Source: CNBC-TV18

There would be a marginal impact on their earnings because most of the important products that are to be launched are not from Goa and Pithampur units...

Lupin to engage consultants and site-transfer dozen products to contain fallout of USFDA warning letter

10.03 pm | 07 Nov 2017 |  Source: Moneycontrol.com

The management in its commentary said the USFDA warning letter didn’t mention anything about data integrity but expressed concerns over handling of ...

USFDA's warning letter for Lupin to hit new approvals and jeopardise US business

5.12 pm | 07 Nov 2017 |  Source: Moneycontrol.com

Analysts tracking the company called it a huge blow as the two plants contribute around 30-40 percent of the sales and a large pipeline of abbreviated...

Lupin gets combined warning letter from USFDA for Goa and Indore sites

1.39 pm | 07 Nov 2017 |  Source: Moneycontrol.com

The company's formulation manufacturing facilities at Goa and Indore (Pithampur Unit II) has received warning letter from USFDA....

Lupin touches 52-week low on warning letter from USFDA to Goa & Indore sites 

1.25 pm | 07 Nov 2017 |  Source: Moneycontrol.com

The company's formulation manufacturing facilities at Goa and Indore (Pithampur Unit II) has received warning letter from USFDA....

News as-it-happened: HDFC Standard Life IPO subscribed 46% on Day 1

6.59 am | 07 Nov 2017 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

Hold Lupin; target of Rs 1030: Reliance Securities

4.56 pm | 06 Nov 2017 |  Source: Moneycontrol.com

Reliance Securities recommended hold rating on Lupin with a target price of Rs 1030 in its research report dated October 31, 2017....

Buy Lupin; target of Rs 1565: HDFC Securities

4.08 pm | 03 Nov 2017 |  Source: Moneycontrol.com

HDFC Securities is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1565 in its research report dated October 31, 20...

Lupin gains 1% on USFDA approval to launch tablets in US market

9.24 am | 03 Nov 2017 |  Source: Moneycontrol.com

Lupin’s Doxycycline Hyclate Tablets USP, 75 mg and 150 mg are the AB rated generic equivalent of Aqua Pharmaceuticals, LLC’s Acticlate Tablets, 75...

Lupin launches tablets in US to treat infections

7.25 pm | 02 Nov 2017 |  Source: PTI

The 75 mg and 150 mg tablets were launched after receiving the approval from the United States Food and Drug Administration (USFDA), Lupin said in a f...

Buy Lupin; target of Rs 1187: KR Choksey

4.40 pm | 01 Nov 2017 |  Source: Moneycontrol.com

KR Choksey is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1187 in its research report dated October 31, 2017....

Lupin Q2 profit seen down 39% at Rs 404 cr, US business may decline 26% 

12.15 pm | 30 Oct 2017 |  Source: CNBC-TV18

EBITDA (earnings before interest, tax, depreciation and amortisation) may fall 23 percent year-on-year to Rs 791 croe and margin may contract 414 basi...

1 2 3 4 5
Quick Links for Lupin
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.